Impact of Short Term Consumption of Diets High in Either Non-Starch Polysaccharides or Resistant Starch in Comparison with Moderate Weight Loss on Indices of Insulin Sensitivity in Subjects with Metabolic Syndrome |
| |
Authors: | Gerald E. Lobley Grietje Holtrop David M. Bremner A. Graham Calder Eric Milne Alexandra M. Johnstone |
| |
Affiliation: | 1.Obesity and Metabolic Health Division, Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB21 9SB, UK; E-Mails: (D.M.B.); (A.G.C.); (E.M.); (A.M.J.).;2.Biomathematics and Statistics Scotland, Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB21 9SB, UK; E-Mail: |
| |
Abstract: | This study investigated if additional non-starch polysaccharide (NSP) or resistant starch (RS), above that currently recommended, leads to better improvement in insulin sensitivity (IS) than observed with modest weight loss (WL). Obese male volunteers (n = 14) were given an energy-maintenance (M) diet containing 27 g NSP and 5 g RS daily for one week. They then received, in a cross-over design, energy-maintenance intakes of either an NSP-enriched diet (42 g NSP, 2.5 g RS) or an RS-enriched diet (16 g NSP, 25 g RS), each for three weeks. Finally, a high protein (30% calories) WL diet was provided at 8 MJ/day for three weeks. During each dietary intervention, endogenous glucose production (EGP) and IS were assessed. Fasting glycaemia was unaltered by diet, but plasma insulin and C-peptide both decreased with the WL diet (p < 0.001), as did EGP (−11%, p = 0.006). Homeostatis model assessment of insulin resistance improved following both WL (p < 0.001) and RS (p < 0.05) diets. Peripheral tissue IS improved only with WL (57%–83%, p < 0.005). Inclusion of additional RS or NSP above amounts currently recommended resulted in little or no improvement in glycaemic control, whereas moderate WL (approximately 3 kg fat) improved IS. |
| |
Keywords: | insulin sensitivity stable isotope kinetics non-starch polysaccharides resistant starch weight loss Minimal Models metabolic syndrome |
|
|